Skip to main content
SpringerLink
Log in

Vaccination for the prevention of pneumococcal meningitis

  • Clinical Trials Report
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dery MA, Hasbun R: Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep 2007, 9:301–307.

    Article  PubMed  Google Scholar 

  2. Black S, Shinefield H, Fireman B, et al.: Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000, 19:187–195.

    Article  PubMed  CAS  Google Scholar 

  3. Whitney CG, Farley MM, Hadler J, et al.: Decline in invasive pneumococcal disease after introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737–1746.

    Article  PubMed  Google Scholar 

  4. Kaplan SL, Mason EO, Wald ER, et al.: Decrease of invasive pneumococcal infections in children among 8 children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004, 113:443–449.

    Article  PubMed  Google Scholar 

  5. Poehling KA, Talbot TR, Griffin MR, et al.: Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006, 295:1668–1674.

    Article  PubMed  CAS  Google Scholar 

  6. Casado-Flores J, Rodrigo C, Aristegul J, et al.: Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008, 27:1020–1022.

    Article  PubMed  Google Scholar 

  7. Munoz-Almagro C, Jordan I, Gene A, et al.: Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174–182.

    Article  PubMed  CAS  Google Scholar 

  8. Jacobs MR, Good CE, Bajaksouzian S, Windau AR: Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008, 47:1388–1395.

    Article  PubMed  Google Scholar 

  9. Ardanuy C, Tubau F, Pallares R, et al.: Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997–2007. Clin Infect Dis 2009, 48:57–64.

    Article  PubMed  Google Scholar 

  10. Tunkel AR, Hartman BJ, Kaplan SL, et al.: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267–1284.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drexel University College of Medicine, Philadelphia, USA

    Allan R. Tunkel

  2. Department of Medicine, Monmouth Medical Center, New Jersey, USA

    Allan R. Tunkel

  3. 300 Second Avenue, Room G417, Long Branch, NJ, 07740, USA

    Allan R. Tunkel

Authors
  1. Allan R. Tunkel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Allan R. Tunkel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tunkel, A.R. Vaccination for the prevention of pneumococcal meningitis. Curr Infect Dis Rep 11, 257–258 (2009). https://doi.org/10.1007/s11908-009-0038-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0038-y

Keywords

Search

Navigation